Life Sciences Investment Banking

An experienced team in a vibrant sector.

Raymond James Life Sciences practice provides comprehensive advisory and financing capabilities to innovative businesses in the biotechnology, specialty pharmaceutical and generic pharmaceutical sectors. Companies within the biopharma industry continue to face the disruptive forces that require them to tailor their strategies in the continually evolving business environment. Our team provides our clients with solutions based on our deep relationships with company management teams as well as venture, private equity and public market investors.

Life Sciences Subsector Expertise

  • Biotechnology
  • Specialty Pharmaceuticals

Senior Banking Team

Stu Barich
Stuart Barich
Managing Director
New York
   
Read Bio
Rainer Hepberger
Managing Director
Munich
   
Bio-no-photo
Marwan Kubursi
Managing Director
Toronto
   
David Stubbs
Managing Director
San Francisco
   
Read Bio
George Billington
George Billington
Senior Vice President
New York
   
Deborah Gerewitz
Deborah Gerewitz
Vice President
New York
   
Read Bio
Steven Lowry
Vice President
San Francisco
   
Read Bio

Transaction History

Transaction history may include a transaction completed by a Raymond James banker while at a former firm.

Recent News

Investment Banking  |  December 13, 2018
Raymond James Corporate Finance adds Prof Eric Claassen to its European Advisory Board

Read More
Investment Banking  |  November 26, 2018
Raymond James Hires Veteran Investment Banker John Barrymore for Consumer Practice

Read More
Investment Banking  |  November 19, 2018
Raymond James adds Senior Financial Services Investment Banker to London practice

Read More